Market Tracker

05/01 6:02pm ET

CytRx Corp (NASDAQ:CYTR)

3.70
Delayed Data
As of May 01
 -0.69 / -15.72%
Today’s Change
2.08
Today|||52-Week Range
5.46
+35.04%
Year-to-Date

Today’s Trading

Previous close4.39
Today’s open4.32
Day’s range3.68 - 4.33
Volume3,275,578
Average volume (3 months)1,039,866
Market cap$206.2M
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+61.81%
Earnings growth (this year)-68.64%
Earnings growth (next 5 years)--
Revenue growth (last year)-66.67%
P/E ratioNM
Price/Sales1,489.77
Price/Book3.04

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.42+3.60%
PLXProtalix Biotherapeu...-0.02-0.91%
ENZYEnzymotec Ltd-0.19-2.10%
PSTIPluristem Therapeuti...+0.08+3.02%
Data as of 4:01pm ET, 05/01/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$100.0K
Annual profit (last year)-$30.1M
Net profit margin-30,117.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts